Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Goossens

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Leukemia|August 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemiaPatrícia Amaral, Rhona Christie, Daisy O F Gresham, et al.
Neuron|January 15, 2013
Directed migration of cortical interneurons depends on the cell-autonomous action of Sip1Veronique van den Berghe, Elke Stappers, Bram Vandesande, et al.
Cell Death and Differentiation|May 9, 2025
Development and validation of a high-throughput screening pipeline of compound libraries to target EMTSven Jonckheere, Joachim Taminau, Jamie Adams, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Cancers|February 11, 2023
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic LymphomaLien Provez, Tom Putteman, Mattias Landfors, et al.
The Journal of Experimental Medicine|October 28, 2015
Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejectionMary J van Helden, Steven Goossens, Cécile Daussy, et al.
The Journal of Experimental Medicine|August 18, 2021
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in miceTim Pieters, Sara T'Sas, Stijn Vanhee, et al.
Blood|April 22, 2020
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Julie Morscio, Lindy Reunes, et al.
Haematologica|March 13, 2016
LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19Hetty H Helsmoortel, Barbara De Moerloose, Tim Pieters, et al.
Hemasphere|March 11, 2024
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Leukemia|August 14, 2025
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemiaPatrícia Amaral, Rhona Christie, Daisy O F Gresham, et al.
Neuron|January 15, 2013
Directed migration of cortical interneurons depends on the cell-autonomous action of Sip1Veronique van den Berghe, Elke Stappers, Bram Vandesande, et al.
Cell Death and Differentiation|May 9, 2025
Development and validation of a high-throughput screening pipeline of compound libraries to target EMTSven Jonckheere, Joachim Taminau, Jamie Adams, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Cancers|February 11, 2023
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic LymphomaLien Provez, Tom Putteman, Mattias Landfors, et al.
The Journal of Experimental Medicine|October 28, 2015
Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejectionMary J van Helden, Steven Goossens, Cécile Daussy, et al.
The Journal of Experimental Medicine|August 18, 2021
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in miceTim Pieters, Sara T'Sas, Stijn Vanhee, et al.
Blood|April 22, 2020
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Julie Morscio, Lindy Reunes, et al.
Haematologica|March 13, 2016
LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19Hetty H Helsmoortel, Barbara De Moerloose, Tim Pieters, et al.
Hemasphere|March 11, 2024
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Pageof 10